Saba, N.F.; Vijayvargiya, P.; Vermorken, J.B.; Rodrigo, J.P.; Willems, S.M.; Zidar, N.; de Bree, R.; Mäkitie, A.; Wolf, G.T.; Argiris, A.;
et al. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era. Cancers 2022, 14, 1202.
https://doi.org/10.3390/cancers14051202
AMA Style
Saba NF, Vijayvargiya P, Vermorken JB, Rodrigo JP, Willems SM, Zidar N, de Bree R, Mäkitie A, Wolf GT, Argiris A,
et al. Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era. Cancers. 2022; 14(5):1202.
https://doi.org/10.3390/cancers14051202
Chicago/Turabian Style
Saba, Nabil F., Pooja Vijayvargiya, Jan B. Vermorken, Juan P. Rodrigo, Stefan M. Willems, Nina Zidar, Remco de Bree, Antti Mäkitie, Greg T. Wolf, Athanassios Argiris,
and et al. 2022. "Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era" Cancers 14, no. 5: 1202.
https://doi.org/10.3390/cancers14051202
APA Style
Saba, N. F., Vijayvargiya, P., Vermorken, J. B., Rodrigo, J. P., Willems, S. M., Zidar, N., de Bree, R., Mäkitie, A., Wolf, G. T., Argiris, A., Teng, Y., & Ferlito, A.
(2022). Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era. Cancers, 14(5), 1202.
https://doi.org/10.3390/cancers14051202